Market Moves
Bill Ackman commits $400 million to a new brain research institute after his daughter's brain haemorrhage
Hedge fund manager Bill Ackman and designer Neri Oxman announced the Ackman Oxman Institute (AOI) on 19-20 August 2026, seeded with $400 million in Pershing Square Inc. stock and a stated further commitment of similar or greater size in a form other than Pershing Square stock. The institute focuses on brain research, rehabilitation, longevity, and human optimization, with Mount Sinai as an important clinical partner. Ackman cited Neuralink, Precision Neuroscience, Synchron, Science Corp and Nudge as examples of the BCI field the institute will engage with, without claiming direct equity in any of them.